Stocks
Emergent BioSolutions Inc.EBS
NYSEHealthcareBiotechnology$8.07-0.68%
Specializing in medical countermeasures, this biopharmaceutical company develops vaccines and therapeutics for public health threats. Investors monitor Emergent BioSolutions for its government contracts and niche focus on biodefense and infectious disease products.
Market Cap: $423.8M52W Range: $4.02 – $14.06
Congressional Interest in Emergent BioSolutions Inc. (EBS)
8 members of Congress have disclosed 19 trades in Emergent BioSolutions Inc. (EBS), a Healthcare company. The buy/sell breakdown shows 10 purchases versus 9 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
19
Unique Politicians
8
Buys
10
Sells
9
Who in Congress Is Trading EBS?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2024-12-11 | STEVE COHEN | sell | $1K – $15K |
| 2023-06-29 | Rohit Khanna | buy | $1K – $15K |